Amneal (AMRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the ...

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. How do you find the right combination ...

With a potential rate cut on the horizon and a solid economic backdrop, investors can capitalize on relative price strength ...

The latest trading day saw Coca-Cola (KO) settling at $60.81, representing a -1.52% change from its previous close.

JPMorgan Chase & Co. (JPM) closed at $240.85 in the latest trading session, marking a -1% move from the prior day.

In 2025, the artificial intelligence (AI) theme is looking to be powerful yet again thanks to snowballing demand. And these ...

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 3rd: ...

For years, electricity demand in the U.S. was relatively stable, but that is expected to change as data centers need more ...

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further growth in 2025.

Another notable valuation metric for MAKSY is its P/B ratio of 2.76. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For ...